GmNN1/FT2a interacted with GmNYFA-C in the BiFC assay. by Xinxin Li (281237)

Gene specific primers used for <i>GmNN1/FT2a</i> fine mapping. by Xinxin Li (281237)

BIT225 dose response curves for SARS-CoV-2 inhibition in cell culture. by Gary Ewart (16793017)

Subjects:

No effect of BIT225 on Ca²⁺-induced endogenous currents in Xenopus oocytes. by Gary Ewart (16793017)

Subjects:

Phenotype and molecular identification of <i>GmNN1/FT2a</i> in stable transgenic soybean plants. by Xinxin Li (281237)

The GmNN1/FT2a-GmNFYA-C-GmENOD40 module regulates soybean nodulation. by Xinxin Li (281237)

Mechanical data for the two drill bits in the MIPS system (MIPS GS, MIPS WD) and the single drill bits in the MONO system at different feed rates (mm/s). The data are shown as the... by Marsel Ganeyev (21453399)

Application of Machine Learning-Based Models to Understand and Predict Critical Flux of Oil-in-Water Emulsion in Crossflow Microfiltration by Henry J. Tanudjaja (12106715)

Subjects:

Temporal profiles of the key BO-NN features. by Julia Berezutskaya (9080269)

“…The shifts associated with non-significant prediction accuracies are greyed-out. <b>(c)</b> The results of the MDS for the key BO-NN features. …”

Antiviral activity of BIT225 in Calu-3 and Vero-E6 cells infected with SARS-CoV-2. by Gary Ewart (16793017)

Subjects:

Dose-dependent viral load, infectious titre and cytokine responses in serum of mice treated with BIT225 for 7 days. by Gary Ewart (16793017)

Subjects:

Data for S5 Fig. by Gary Ewart (16793017)

Subjects:

Data for S4 Fig. by Gary Ewart (16793017)

Subjects:

Resting membrane potential in X. laevis oocytes injected with 20 ng KChIP2.1, 50 nl water and un-injected. n = 10–11. by Gary Ewart (16793017)

Subjects:

Data for the mouse studies (Fig 2, Fig 3, Fig 4, S7 Fig, S8 Fig and S9 Fig) and data for the in vitro dose-response experiments (Table 1, S1 Table and S1 Fig). by Gary Ewart (16793017)

Subjects:

Treatment of SARS-CoV-2 infected K18-hACE2 mice with BIT225 starting 24 h before (pre), or 24 h or 48 h after (post) infection. by Gary Ewart (16793017)

Subjects:

Efficacy and dose-dependence of seven-day treatment of SARS-CoV-2 infected K18-hACE2 mice with BIT225. by Gary Ewart (16793017)

Subjects:

Calcium induced endogenous current data for S3 Fig. by Gary Ewart (16793017)

Subjects:

Twelve-day treatment of SARS-CoV-2 infected K18-hACE2 mice with BIT225. by Gary Ewart (16793017)

Subjects:

Cytokine levels at Day 12 post infection in serum of mice treated with BIT225 starting 24 h before (pre), or 24 h or 48 h after (post) infection. by Gary Ewart (16793017)

Subjects: